S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

ORMP Oramed Pharmaceuticals Inc

2.41

0.065 (2.77%)

Last Updated: 09:12:08

Delayed by 15 minutes

Confidential Treatment Order (ct Order)

This regulatory filing also includes additional resources:
filename1.pdf

Oramed Pharmaceuticals (NASDAQ:ORMP)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Oramed Pharmaceuticals Charts.

Oramed Pharmaceuticals (NASDAQ:ORMP)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Oramed Pharmaceuticals Charts.

Oramed Pharmaceuticals Inc. News

Scilex Holding Company Announces Repayment in Full of the Remaining Balance of Convertible Debentures and Early Payment of the Senior Secured Promissory Note, Paving the Way for Future Growth and Innovation
Tuesday 19 March 2024 (1 month ago) • GlobeNewswire Inc.

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Wednesday 6 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 20 February 2024 (2 months ago) • Edgar (US Regulatory)

Oramed Letter to Shareholders
Tuesday 20 February 2024 (2 months ago) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 30 January 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 23 January 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 19 January 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 8 January 2024 (4 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 8 January 2024 (4 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 8 January 2024 (4 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 8 January 2024 (4 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 8 January 2024 (4 months ago) • Edgar (US Regulatory)

More Oramed Pharmaceuticals Inc. News Articles

Voip Pal Com (QB)

Brookmount Explorations (PK)

Global Developments (PK)

BlackStar Enterprise (PK)

NaturalShrimp (QB)

Globestar Therapeutics (PK)

Atacama Resources (PK)

MicroCloud Hologram

Elite Pharmaceuticals (QB)

Bell Buckle (PK)

Progressive Care (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions